Stephanie Schmidt on NSCLC The Immunomodulatory Impact of Neoadjuvant Chemotherapy and Immune-Based Treatments – The ASCO Post

Solid TumorsImmunotherapy The ASCO Post Staff Kim A. Reiss, MD, on HER2-Overexpressing Solid Tumors: First-in-Human Study of Anti-HER2 CAR Macrophages Kim A. Reiss, MD, of the University of Pennsylvania, discusses results of a phase I trial of a CAR-M engineered macrophage cancer therapy, known as CT-0508, for patients with solid tumors…

Read the full article here

Related Articles